to commercially deploy a platform that delivers a ‘pro-healing’ microenvironment for the leading causes of preventable blindness. The company’s leading application will be in ocular surface diseases

The University of Birmingham has created a new spinout, Healome Therapeutics Ltd, to commercially deploy a platform that delivers a ‘pro-healing’ microenvironment for the leading causes of preventable blindness.The company’s leading…